CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Closure of Iatrogenic Atrial Septal Defect Following Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid Patients TAVI Represents an Anti-Inflammatory Therapy via Reduction of Shear Stress Induced, Piezo-1-Mediated Monocyte Activation Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis Adaptive development of concomitant secondary mitral and tricuspid regurgitation after transcatheter aortic valve replacement Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium Vulnerable or High-Risk Plaque: A JACC: Cardiovascular Imaging Position Statement Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial

Clinical Trial15 Oct 2020

JOURNAL:Circulation. Article Link

Closure of Iatrogenic Atrial Septal Defect Following Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial

P Lurz , M Unterhuber , KP Rommel et al. Keywords: TMVR;

Full Text PDF